Dr Reddy’s Laboratories
-
November 17, 2020, Tuesday
Pfizer moves US court against Aurobindo Pharma, Dr Reddy's on cancer drug
Pfizer Inc alleged that the drug makers were planning separately to come out with generic versions of its blockbuster ...
-
November 02, 2020, Monday
DCGI rejects DRL's proposal, denies full marketing rights for Remdesivir
Emergency use authorisation to continue; recently, WHO had raised doubts about efficacy of drug in treatment of Covid-19 patients
-
October 29, 2020, Thursday
Dr Reddy's partners Dept of Biotech for vaccine clinical trials in India
Dr Reddy's Laboratories Ltd announced its partnership with BIRAC, DBT, for advisory support on clinical trials of Sputnik V ...
-
October 28, 2020, Wednesday
Dr Reddy's Q2 PAT down 30% to Rs 762 crore from Rs 1,092 cr year-ago
The PAT of Dr Reddys Laboratories for the quarter ended on September 30, 2020, was down by 30 per cent at Rs 762.3 crore compared ...
-
October 23, 2020, Friday
USFDA approves Remdesivir as first Covid-19 therapy amid WHO reservations
Approval unlikely to increase prices immediately as Gilead has said licenses are royalty-free until the end of the health ...
-
October 22, 2020, Thursday
Dr Reddy's Labs isolates data centre services due to cyber attack
Dr Reddy's Laboratories on Thursday said it has isolated all data centre services following a cyber-attack
-
October 20, 2020, Tuesday
Dr Reddy's launches Famotidine generic product in US to treat acidity
Dr Reddy's Laboratories on Tuesday said it has launched over-the-counter (OTC) drug Famotidine tablets, used to treat ...
-
October 17, 2020, Saturday
Dr Reddy's gets DCGI nod to conduct Covid-19 vaccine phase 2/3 human trails
Dr Reddy's and Russian Direct Investment Fund on Saturday announced that they have received approval from DCGI to conduct an ...
-
October 16, 2020, Friday
Panel urges granting Dr Reddy's permission for Russia vaccine phase 2 trial
The SEC had on October 5 asked the firm to re-apply stating it will have to conduct both phase 2 and 3 clinical trials and cannot ...
-
October 15, 2020, Thursday
Dr Reddy's: Progress in Covid vaccine trials to boost firm's growth outlook
Good momentum in US and domestic sales, along with Covid-19 treatment portfolio is already driving analysts to upgrade earnings ...
